Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,920,997 papers from all fields of science
Search
Sign In
Create Free Account
2-n-dodecyltetrahydrothiophene
Known as:
2-DO-TTH
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Thiophenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A Retrospective Study Comparing the Effectiveness and Safety of EXOSEAL Vascular Closure Device to Manual Compression in Patients Undergoing Percutaneous Transbrachial Procedures.
Xiao-long Wei
,
Tonglei Han
,
+6 authors
Z. Jing
Annals of Vascular Surgery
2019
Corpus ID: 201759177
2019
2019
Differentielle ttH-Wirkungsquerschnittsmessungen am Hl-LCH
Florian Henkes
,
U. Husemann
,
M. Schröder
,
Philip Keicher
2019
Corpus ID: 187664082
2018
2018
Management of male hypogonadism and testosterone therapy: European Association of Urology position statement on the role of the urologist.
A. Alcántara Montero
Actas Urológicas Españolas
2018
Corpus ID: 205263522
2017
2017
Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data
S. Hiroi
,
K. Sugano
,
Shiro Tanaka
,
K. Kawakami
BMJ Open
2017
Corpus ID: 5003761
Objectives To explore the prevalence of Helicobacter pylori infection in Japan and the trends of its eradication therapy before…
Expand
1974
1974
Tth pseudotherapeutic community: an examination of antitherapeutics forces of psychiatric units.
M. Sacks
,
W. Carpenter
Hospital & community psychiatry
1974
Corpus ID: 32544187
If a psychiatric unit is to be effectively therapeutic, its staff must avoid the pitfalls that can turn it into a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE